Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1975 of 6351
-
New drug shows promise for Long-Term control of painful skin condition
Disease control CompletedThe purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Negative test, safe concert? study tests Pre-Event screening
Prevention CompletedThe objective is to demonstrate if there is no increase in the risk of Sars-Cov-2 salivary carriage 7 days after a concert in the group participating in the event compared to a non participating group who stayed at home. The hypothesis is that a systematic screening of Sars-Cov-…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Freezing heart tissue may stop deadly rhythms
Disease control CompletedA prospective, single-arm, multi-center, pre-market, clinical study designed to provide safety and performance data regarding the use of the Adagio Medical VT Cryoablation System in the treatment of ventricular tachycardia.
Sponsor: Adagio Medical • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Walk and eat smart: new study aims to ward off dementia and diabetes
Prevention Recruiting nowThis is a multicenter, randomized 2-arm clinical trial of two lifestyle interventions varying in intensity and format, in 400 older African American and non-Hispanic whites at increased risk of cognitive decline and dementia in the East San Francisco Bay Area. The trial will incl…
Sponsor: University of California, Davis • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
3D-Printed mouth guards could ease radiation side effects for cancer patients
Symptom relief Recruiting nowThis clinical trial studies the effect of customized 3 dimensional (3D) printed oral tents on patients with head and neck cancer who are receiving radiotherapy. Oral stents are made from the impression of patients' mouth and cover patients' teeth and gums during radiation therapy…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Can CBD calm PTSD? new trial seeks answers
Symptom relief Recruiting nowThis will be a randomized placebo controlled study to test the efficacy of cannabidiol (CBD) as a treatment for symptoms of post-traumatic stress disorder (PTSD). Subjects, 120 in total, will be males and females with PTSD, half of which will have comorbid mild traumatic brain in…
Phase 2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Smartphone app aims to keep colorectal surgery patients out of the hospital
Disease control Recruiting nowBackground: Colorectal surgery includes surgery for colorectal cancer, inflammatory bowel disease and other benign diseases such as diverticulitis. In Canada, approximately 21,000 colorectal surgeries are performed each year. Patients undergoing colorectal surgery face high rates…
Sponsor: Mount Sinai Hospital, Canada • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for MDS patients: drug may end need for platelet transfusions
Disease control OngoingThis study is designed to evaluate the efficacy and safety of eltrombopag monotherapy in Japanese adult patients with platelet transfusion-dependent lower-risk Myelodysplastic syndromes (LR-MDS).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a quick brain zap ease depression? new study seeks the sweet spot.
Symptom relief OngoingHigh frequency repetitive transcranial magnetic stimulation (rTMS) has been shown to be safe, feasible, and acceptable. Conventionally, rTMS investigations have relied on rational decision trees for dosage determination. The purpose of this study is to systematically examine an a…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Can tailored drugs after surgery keep melanoma from coming back?
Disease control Recruiting nowThe purpose of this study is to assess rate of disease relapse and hazard rate of disease relapse after neoadjuvant therapy based on the statuses of pathologic complete response or non-pathologic complete response, and postoperative adjuvant therapy.
Early phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New targeted drug shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThe study will determine the safety, tolerability, recommended Phase 2 dose (RP2D) and preliminary efficacy of BGB-11417 as monotherapy and in combination with azacitidine in participants with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)or MDS/myeloproliferativ…
Phase 1/2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New eye drug PRO-169 takes on lucentis in major trial
Disease control CompletedPhase III clinical study to evaluate the efficacy, expressed as improvement in visual acuity in patients suffering diabetic macular edema after one year of treatment with PRO-169, compared to treatment with Lucentis® (ranibizumab).
Phase 3 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Blood test may predict which lung cancer patients respond to immunotherapy
Knowledge-focused Recruiting nowPatient with histologically proven NSCLC in a metastatic stage, treatment naïve and eligible for first-line treatment with immune checkpoint inhibitor. Combination with chemotherapy is possible. Presence of a mutation after NGS analysis is required for ctDNA follow-up.
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:14 UTC
-
Could one pill a day control this esophagus disease as well as two?
Disease control OngoingThe purpose of this study is to prove the non-inferiority of a 6-weeks treatment with 1 mg budesonide orodispersible tablets BID versus 2 mg budesonide orodispesible tabletss for the induction of clinico-pathological remission in adult patients with active eosinophilic esophagiti…
Phase 3 • Sponsor: Dr. Falk Pharma GmbH • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Acupuncture needles take on chemo nerve pain in major trial
Symptom relief OngoingThis study is a randomized controlled trial of electroacupuncture (referred to as EA) versus sham acupuncture (referred to as EA) as effective treatments for Chemotherapy-Induced Peripheral Neuropathy (CIPN) pain in cancer survivors.
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis phase I trial identifies the side effects and best dose of DS-8201a and olaparib in treating patients with HER2-expressing cancers that have spread to other places in the body or cannot be removed by surgery or ovarian cancer that remains despite treatment with a platinum tr…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a precise radiation beam spare balance? a study investigates
Knowledge-focused Recruiting nowVestibular schwannomas are benign lesions of the ponto-cerebellar angle that are potentially dangerous because of their growth in a cramped space and the compressive phenomena they can cause. Stereotactic Gammaknife radiosurgery is a treatment option that can be offered for evolu…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New PSMA scan aims to spot hidden prostate cancer spread
Diagnosis Stopped earlyIn France, prostate cancer is the most common cancer in men over 50 years of age (nearly 50,000 new cases per year) and is the second most common cause of cancer death in men (approximately 9,000 deaths per year). Although mortality has been declining since the end of the 1990s (…
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New drug aims to slow kidney failure in chronic disease patients
Disease control CompletedOutcome of use of a novel Modulator of Oxidative Phosphorylation on kidney function in patients with Chronic Kidney Disease
Sponsor: Neukidney Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:48 UTC
-
AI-Powered therapy shows promise in curbing teen violence
Disease control CompletedThis study will use a randomized control trial (RCT) design to administer two versions of a multisession remote behavioral intervention for youth seeking Emergency Department care for a violent injury with the goal to reduce their violence involvement and associated negative beha…
Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC